For: | Zhang YW, Zhang YL, Pan H, Wei FX, Zhang YC, Shao Y, Han W, Liu HP, Wang ZY, Yang SH. Chemotherapy for patients with gastric cancer after complete resection: A network meta-analysis. World J Gastroenterol 2014; 20(2): 584-592 [PMID: 24574729 DOI: 10.3748/wjg.v20.i2.584] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i2/584.htm |
Number | Citing Articles |
1 |
Shuai Wang, Wujun Chen, Hualong Yu, Zhengming Song, Qian Li, Xin Shen, Yudong Wu, Lei Zhu, Qingxia Ma, Dongming Xing. lncRNA ROR Promotes Gastric Cancer Drug Resistance. Cancer Control 2020; 27(1) doi: 10.1177/1073274820904694
|
2 |
Huan-Fu Hu, Zheng Wang, Wen-Li Tang, Xue-Ming Fu, Xiang-Jun Kong, Ying-Kun Qiu, Sheng-Yan Xi. Effects of Sophora flavescens aiton and the absorbed bioactive metabolite matrine individually and in combination with 5-fluorouracil on proliferation and apoptosis of gastric cancer cells in nude mice. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1047507
|
3 |
Zhang Yu Huai, Wei Feng Xian, Luo Chang Jiang, Wang Xi Chen. Submucosal Injection Solution for Endoscopic Resection in Gastrointestinal Tract: A Traditional and Network Meta-Analysis. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/702768
|
4 |
Jianwen Li. Brassinin Inhibits Progression and Induces Apoptosis in Gastric Cancer Cells by Regulating NF-κB Signaling Cascade. Journal of Biomedical Nanotechnology 2023; 19(9): 1575 doi: 10.1166/jbn.2023.3629
|
5 |
Keun-Seok Hong, Hyemin Kim, Seon-Hee Kim, Minju Kim, Jiyun Yoo. Calponin 3 Regulates Cell Invasion and Doxorubicin Resistance in Gastric Cancer. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/3024970
|
6 |
Zhi‑Peng Ji, Ling Qiang, Jian‑Liang Zhang. Transcription activated p73-modulated cyclin D1 expression leads to doxorubicin resistance in gastric cancer. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5642
|
7 |
Vicente Ramos‐Santillan, Patricia Friedmann, Mariam Eskander, Jennifer Chuy, Michael Parides, Haejin In. The order of surgery and chemotherapy matters: Multimodality therapy and stage‐specific differences in survival in gastric cancer. Journal of Surgical Oncology 2023; 127(1): 56 doi: 10.1002/jso.27110
|
8 |
Gayle M. Gordillo, Ayan Biswas, Savita Khanna, James M. Spieldenner, Xueliang Pan, Chandan K. Sen. Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial Cells. Journal of Biological Chemistry 2016; 291(19): 10089 doi: 10.1074/jbc.M115.688879
|
9 |
Zhaolun Cai, Yuan Yin, Chaoyong Shen, Jian Wang, Xiaonan Yin, Zhixin Chen, Ye Zhou, Bo Zhang. Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years. Surgical Oncology 2018; 27(3): 563 doi: 10.1016/j.suronc.2018.07.011
|
10 |
FENGLIN CHEN, MINGKAI ZHUANG, CANMEI ZHONG, JUN PENG, XIAOZHONG WANG, JIANYING LI, ZHIXIN CHEN, YUEHONG HUANG. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway. Oncology Reports 2015; 33(1): 457 doi: 10.3892/or.2014.3550
|
11 |
Louis de Mestier, Sophie Lardière-Deguelte, Julien Volet, Reza Kianmanesh, Olivier Bouché. Recent insights in the therapeutic management of patients with gastric cancer. Digestive and Liver Disease 2016; 48(9): 984 doi: 10.1016/j.dld.2016.04.010
|
12 |
Daniele Marrelli, Karol Polom, Giovanni de Manzoni, Paolo Morgagni, Gian Luca Baiocchi, Franco Roviello. Multimodal treatment of gastric cancer in the west: Where are we going?. World Journal of Gastroenterology 2015; 21(26): 7954-7969 doi: 10.3748/wjg.v21.i26.7954
|
13 |
Yun-chao Xu, Xu Liu, Min Li, Yan Li, Chun-yan Li, Ying Lu, Jaceline Sanches, Lu Wang, Yue Du, Li-min Mao, Si-bo Zuo, Hui-ting Liu, Jie Shen, Bo Wang, Li Hou, Lian-hong Li, Jian-wu Tang, Jing-fang Ju, Hong-wei Guan, Bo Song. RETRACTED: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID. Molecular Therapy - Nucleic Acids 2018; 12: 578 doi: 10.1016/j.omtn.2018.06.011
|
14 |
Kenta Shimokawa, Kazumi Wakasugi, Rei Tomonaga, Ken Utsunomiya, Hirotaka Miyamoto, Shintaro Fumoto, Koyo Nishida. Effect of Metabolic Inhibitors on the Hepatic Disposition of 5-Fluorouracil after Application to the Rat Liver Surface. Biological & Pharmaceutical Bulletin 2016; 39(3): 361 doi: 10.1248/bpb.b15-00757
|
15 |
Jiahui Xu, Deying Liu, Huilin Niu, Guifang Zhu, Yangwei Xu, Danli Ye, Jian Li, Qingling Zhang. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. Journal of Experimental & Clinical Cancer Research 2017; 36(1) doi: 10.1186/s13046-016-0487-8
|
16 |
Long Ge, Liangying Hou, Qingxia Yang, Yiting Wu, Xiue Shi, Jiang Li, Kehu Yang. A systematic review and network meta-analysis protocol of adjuvant chemotherapy regimens for resected gastric cancer. Medicine 2019; 98(7): e14478 doi: 10.1097/MD.0000000000014478
|